Health systems in Columbus are pushing the needle on cancer treatment, from proton therapy to consolidated clinics, ...

A Leyland man was initially told he had contracted a tropical virus while travelling in Thailand, but it turned out to be a ...

Boston biotech Beam Therapeutics has announced initial data from a phase 1/2 trial of its gene therapy for a genetic lung and liver disease, with no serious adverse events reported among the nine ...

A multi-institutional team of physicists and engineers has developed a laser-based radiation detection system that operates ...

Three patients who received a high dose of Beam’s treatment saw their levels of AAT rise to an average of 12.4 micrograms. Any level above 11 micrograms is generally regarded as “protective.” ...

The global irradiation apparatus market is expected to grow at a CAGR of 3.5% from 2024 to 2034, reaching USD 8.8 billion by 2034. This growth is driven by the increasing demand for early disease ...

While only a first look at the medicine’s potential, the results Beam disclosed Monday suggest treatment is working as intended, without causing any alarming side effects that could derail testing.

Beam Ther­a­peu­tics said its ex­per­i­men­tal gene edit­ing treat­ment helped low­er lev­els of mu­tant pro­teins and in­crease lev­els of cor­rect­ed pro­teins in … ...